Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are studying the use of transcranial direct current stimulation tDCS, a technique that uses low-intensity electrical currents to influence brain activity, for treating moderate to severe depression. This study aims to compare how effective tDCS is when performed at home versus in a hospital setting, focusing on reducing depressive symptoms six weeks after treatment. The trial also highlights the importance of regular clinical monitoring to ensure safety and proper treatment adherence. Participants are randomly assigned to one of two groups one group receives tDCS treatment at the hospital under nursing supervision, while the other performs self-administered tDCS at home with remote nursing oversight through a digital app that monitors treatment and compliance. The treatment involves 20 sessions over 10 working days, with two 30-minute sessions per day at 2 mA. The study also includes questionnaires, interviews, and monitoring to assess the experience and impact of the treatments. Throughout the study, participants complete various assessments, including depression rating scales and quality of life measures, before, immediately after, and six weeks post-treatment. Nurses provide guidance on device use during hospital visits, and remote monitoring supports adherence for home treatments. Researchers evaluate effectiveness, safety, patient self-reports, and the financial and practical aspects of delivering tDCS in both settings. The study lasts about two months, with follow-ups to measure lasting effects and implementation factors.
Actively Recruiting
ElectroConvulsive Therapy ECT has been used since the 1930s as a treatment mainly for drug-resistant depressive illnesses and has shown effectiveness in other psychiatric conditions. This observational study aims to identify how ECT is practiced in France and to develop research that evaluates and improves the effectiveness of this treatment. There is currently no consensus on the best medical care for ECT in France, and the study seeks to update recommendations that have not been revised since 1997. The study observes patients who are referred for ECT and collects data over time without introducing new treatments or interventions. It focuses on understanding current medical procedures related to ECT and assessing its efficiency in patients from 2018 to 2022. No specific treatment groups or comparators are involved, as this is an observational study. Participants will be monitored through data collection about their treatment and health outcomes during and after ECT. The main outcome measured is the effectiveness of ECT on patients with mental disorders. The study is led by the Centre Hospitalier Henri Laborit and will continue until December 2027. Participants are expected to be patients referred for ECT, with no additional exclusion criteria specified.